Approvals and Clearances - Immunomedics
This article was originally published in Clinica
Immunomedics has received CE marking for CEA-Scan, its imaging agent for detecting colorectal cancer. The company, which is based in Morris Plains, New Jersey, claims that the agent is able to identify 40% more patients who could benefit from operative treatment than other methods. It also identifies twice as many patients for whom surgery is pointless.